What is Design Therapeutics, Inc.'s AOCI?

Design Therapeutics, Inc. (DSGN) reported AOCI of -$268K in Q1 2026.

How has Design Therapeutics, Inc.'s AOCI changed year-over-year?

Design Therapeutics, Inc.'s AOCI decreased by 159.6% year-over-year, from $450K to -$268K.

What is the long-term trend for Design Therapeutics, Inc.'s AOCI?

Over 5 years (2020 to 2025), Design Therapeutics, Inc.'s AOCI has grown at a 20.9% compound annual growth rate (CAGR), from $156K to $403K.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Design Therapeutics, Inc. DSGN AOCI

AOCI at other companies

ALN

Alnylam PharmaceuticalsALNY

-$24.89M+33.6%

Intellia TherapeuticsNTLA

-$240K-123%

CRISPR TherapeuticsCRSP

-$1.94M-147%

Dyne Therapeutics, Inc.DYN

-$137K-157%

Vor BiopharmaVOR

-$706K-3,170%

Taysha Gene Therapies, Inc.TSHA

$985K+143%

Other financials

Income statement

See full

Revenue-—

Operating income-$19.7M+3.5%

Net income-$17.6M+0.4%

EPS (diluted)-$0.29+6.5%

Balance sheet

See full

Cash & equivalents$12.8M-6.6%

Total debt$2.7M+27.7%

Total equity$218.1M-4.3%

Total assets$230.4M-3.0%

Cash flow

See full

Operating cash flow-$16.4M+2.1%

CapEx--100%

Free cash flow-$16.4M+2.6%

Valuation

See full

Market cap$839.42M+295%

Enterprise value$829.39M+313%

Profitability

See full

Operating margin-3,685.8%—

Net margin-3,663.7%—

Returns & leverage

See full

Return on equity-31.3%+19.5pp

Debt / equity0×0.0×

Current ratio22.3×-6.1×

Where this comes from

Reported directly by Design Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Design Therapeutics, Inc.'s aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Design Therapeutics, Inc.'s AOCI?: Design Therapeutics, Inc. (DSGN) reported AOCI of -$268K in Q1 2026.
How has Design Therapeutics, Inc.'s AOCI changed year-over-year?: Design Therapeutics, Inc.'s AOCI decreased by 159.6% year-over-year, from $450K to -$268K.
What is the long-term trend for Design Therapeutics, Inc.'s AOCI?: Over 5 years (2020 to 2025), Design Therapeutics, Inc.'s AOCI has grown at a 20.9% compound annual growth rate (CAGR), from $156K to $403K.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.